Add
KERX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| KERX > SEC Filings for KERX > Form 8-K on 10-Nov-2008 | All Recent SEC Filings |
10-Nov-2008
Results of Operations and Financial Condition, Other Events
On November 10, 2008, Keryx Biopharmaceuticals, Inc. ("Keryx") issued a press release announcing results of operations for the third quarter ended September 30, 2008, and announced that it would host a conference call on November 11, 2008, for investors where Keryx will discuss its results of operations and financial results. A copy of the press release is being furnished as Exhibit 99.1 to this report.
On November 10, 2008, Keryx issued a press release announcing that data from its Phase I/II clinical trial of KRX-0401 (perifosine) has been selected for oral presentation at the upcoming 50th Annual Meeting of the American Society of Hematology ("ASH"), to be held in San Francisco beginning December, 2008. A copy of this press release is being furnished as Exhibit 99.2 to this report, and the abstract of the study is being furnished as Exhibit 99.3 to this report.
|
|